Overview

Restless Legs Patient Study On Absorption, Distribution, Metabolism And Excretion Of Ropinirole And The Effect Of Food

Status:
Completed
Trial end date:
2006-12-12
Target enrollment:
Participant gender:
Summary
This study in RLS patients is designed to assess the affect food has on the absorption, distribution, metabolism and excretion of ropinirole (by dosing some patients in the fasted state and other patients following a high-fat breakfast), and to assess the difference in absorption, distribution, metabolism and excretion of ropinirole if patients are given two 3mg ropinirole tablets versus one 6mg tablet.
Phase:
Phase 1
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Ropinirole